INS and chronic kidney disease: Consistent with previous studies [24,25,26,32,33,34,35], our study suggested MET monotherapy as the most frequently prescribed antidiabetic regimen for CKD patients, decreasing significantly as the CKD stage advanced in favor of insulin and glinides (Figure 2).